Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients.
about
Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact.Treatment of chronic hepatitis C in patients with HIV/HCV coinfectionCannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients.TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.
P2860
Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Anti-hepatitis C virus treatme ...... s C virus coinfected patients.
@en
Anti-hepatitis C virus treatme ...... s C virus coinfected patients.
@nl
type
label
Anti-hepatitis C virus treatme ...... s C virus coinfected patients.
@en
Anti-hepatitis C virus treatme ...... s C virus coinfected patients.
@nl
prefLabel
Anti-hepatitis C virus treatme ...... s C virus coinfected patients.
@en
Anti-hepatitis C virus treatme ...... s C virus coinfected patients.
@nl
P50
P1476
Anti-hepatitis C virus treatme ...... s C virus coinfected patients.
@en
P2093
Carlo Doglioni
Laura Galli
P304
P356
10.1016/J.BJID.2013.06.005
P50
P577
2013-10-25T00:00:00Z